NaQ SR · Prolonged-Release Sodium Chloride 600mg
A prolonged-release sodium chloride formulation. This page provides general educational information about hyponatraemia and prolonged-release sodium chloride. It is not medical advice — please refer any clinical decisions to a qualified healthcare professional.
NaQ SR is a prolonged-release sodium chloride formulation. The clinical contexts in which slow sodium is generally used include those below. Full product information is available to professionals on request.
Slow sodium tablets should only be used if prescribed by your doctor following a diagnosis. Never self-medicate. If you have been prescribed treatment, the points below are general reminders — always follow your own doctor's instructions.
Low blood sodium is one of the most common electrolyte disorders encountered in clinical practice — and one of the most frequently missed. Recognising it early changes outcomes.
Hyponatraemia is a condition in which blood sodium falls below 135 mmol/L. It is the most common electrolyte disorder in hospitalised patients, affecting 15–30% of admissions. Signs can range from subtle fatigue and cognitive changes to more serious presentations in severe cases. Diagnosis and management should always be guided by a qualified healthcare professional.
Chronic mild hyponatraemia — once considered benign — is now strongly associated with cognitive impairment, increased fracture risk, gait instability, and higher all-cause mortality. Many cases present under the guise of depression, dementia, or simple deconditioning, particularly in elderly patients.
Confusion, poor concentration, memory lapses — often attributed to age or dementia
Persistent tiredness disproportionate to activity or sleep quality
Nausea, vomiting, reduced appetite without identifiable cause
Cramps, spasms, proximal muscle weakness and myalgia
Unsteady walking and increased falls — even at mild serum deficit
Seizures, respiratory arrest in acute severe hyponatraemia (<120 mmol/L)
In general, an immediate-release formulation releases its active ingredient quickly, while a prolonged-release formulation is designed to release it gradually over a longer period. The following explains how prolonged-release formulations work — as general education, not medical advice.
Illustration only. This diagram explains, in general terms, how a prolonged-release formulation is designed to release its active ingredient gradually compared with a rapid-release one. It is general educational information and not a measured product claim.
A brief summary only. This is not a full prescribing document and not medical advice. A representative can share complete product information on request.
General questions about hyponatraemia (low blood sodium) and prolonged-release sodium chloride. This is health awareness information only and is not a substitute for advice from a qualified healthcare professional.
For anything not answered here, please use the enquiry form below.
For more information or any questions, reach out using the details below or send a message through the form.
Send us a message and a representative will get back to you.
Do not take this or any medicine unless it has been prescribed by your doctor following a proper diagnosis. This product is not intended for self-treatment. Please consult a qualified healthcare professional before taking this health product.
This website is provided for general health awareness and educational purposes only. The information here is not medical advice, is not a substitute for consultation with a qualified healthcare professional, and should not be used to diagnose or treat any condition. If symptoms persist, seek medical advice.